InvestorsHub Logo
Followers 35
Posts 2667
Boards Moderated 0
Alias Born 06/08/2014

Re: postes post# 279377

Wednesday, 06/10/2020 9:16:47 PM

Wednesday, June 10, 2020 9:16:47 PM

Post# of 427985
Postes, yes, I remember your response. A couple of things to consider. My guess is the patents on Revlimid have a lot less prior art to poke holes into the patents. I mean how much prior art could there be on a drug that deals with stem cells? If you are a pirate ship, you don't take on the aircraft carrier, but you might take on a supply ship, especially if you think you have a shot.
Thanks for the prayers everyone.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News